Bacteria-induced uroplakin signaling mediates bladder response to infection - Wikidata - awgldk - TriplyDB

Bacteria-induced uroplakin signaling mediates bladder response to infection

Bacteria-induced uroplakin signaling mediates bladder response to infection

http://www.wikidata.org/entity/Q33438417

about

Adhesive Pili in UTI Pathogenesis and Drug Development Perspective: Adhesion Mediated Signal Transduction in Bacterial Pathogens Anatomy and Physiology of the Urinary Tract: Relation to Host Defense and Microbial Infection Glycosylation of uroplakins. Implications for bladder physiopathology Mechanisms of pain from urinary tract infection SNX31: a novel sorting nexin associated with the uroplakin-degrading multivesicular bodies in terminally differentiated urothelial cells Pathogenesis of Streptococcus urinary tract infection depends on bacterial strain and β-hemolysin/cytolysin that mediates cytotoxicity, cytokine synthesis, inflammation and virulence Urothelial signaling.Exploitation of the intestinal microflora by the parasitic nematode Trichuris muris.Cell biology and physiology of the uroepithelium.Waging war against uropathogenic Escherichia coli: winning back the urinary tract Impact of host age and parity on susceptibility to severe urinary tract infection in a murine model.Nervous network for lower urinary tract function.Testosterone suppresses uropathogenic Escherichia coli invasion and colonization within prostate cells and inhibits inflammatory responses through JAK/STAT-1 signaling pathway.Requirement for a uroplakin 3a-like protein in the development of zebrafish pronephric tubule epithelial cell function, morphogenesis, and polarity Transposon mutagenesis identifies uropathogenic Escherichia coli biofilm factors.The repetitive domain of ScARP3d triggers entry of Spiroplasma citri into cultured cells of the vector Circulifer haematoceps.Uropathogenic Escherichia coli induces chronic pelvic pain Asymptomatic bacteriuria Escherichia coli are live biotherapeutics for UTI.Dual sources of vitronectin in the human lower urinary tract: synthesis by urothelium vs. extravasation from the bloodstream.Th1-Th17 cells contribute to the development of uropathogenic Escherichia coli-induced chronic pelvic pain Human bladder uroepithelial cells synergize with monocytes to promote IL-10 synthesis and other cytokine responses to uropathogenic Escherichia coli.Enterococcus faecalis subverts and invades the host urothelium in patients with chronic urinary tract infection Advanced glycation end products facilitate bacterial adherence in urinary tract infection in diabetic mice.Intracellular Uropathogenic E. coli Exploits Host Rab35 for Iron Acquisition and Survival within Urinary Bladder Cells Role of Uropathogenic Escherichia coli Virulence Factors in Development of Urinary Tract Infection and Kidney Damage.MAL facilitates the incorporation of exocytic uroplakin-delivering vesicles into the apical membrane of urothelial umbrella cells.Cytosolic and Calcium-Independent Phospholipases A2 Activation and Prostaglandins E2 Are Associated with Escherichia coli-Induced Reduction of Insulin Secretion in INS-1E Cells.Distinguishing the contribution of type 1 pili from that of other QseB-misregulated factors when QseC is absent during urinary tract infection.A Murine Model for Escherichia coli Urinary Tract Infection.The Tetraspanin-Associated Uroplakins Family (UPK2/3) Is Evolutionarily Related to PTPRQ, a Phosphotyrosine Phosphatase Receptor.Structure, Function, and Assembly of Adhesive Organelles by Uropathogenic Bacteria Histone Deacetylase 6 Regulates Bladder Architecture and Host Susceptibility to Uropathogenic Escherichia coli.A central metabolic circuit controlled by QseC in pathogenic Escherichia coli.Strengths and Limitations of Model Systems for the Study of Urinary Tract Infections and Related Pathologies.Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection.Bacterial biofilms: development, dispersal, and therapeutic strategies in the dawn of the postantibiotic era.Drug and Vaccine Development for the Treatment and Prevention of Urinary Tract Infections.Treatment and prevention of urinary tract infection with orally active FimH inhibitors.From physiology to pharmacy: developments in the pathogenesis and treatment of recurrent urinary tract infections

P2860

Q26752944-54678382-CE7C-4B92-BC60-DAB329DFE8A1 Q26768433-78CB3E42-0BA2-4147-95CE-D5C53449E0FB Q26782602-E74897E2-717F-4F5C-A18E-3F7CEDC2951F Q26823952-99599D63-AAEE-4C9F-B5E2-0C565F0F6BC1 Q27028174-FA0DCD6A-72BF-4593-A3F0-625D279ABFDD Q28589878-9F858841-1555-475E-828D-C53DD8FD30CD Q28972267-57FDE413-DEF3-4E12-96AC-9BDE660F77C1 Q30440958-0F505B64-9C7C-4D30-A82D-47EB6AB9DE7D Q30524457-D2817573-C0D5-4843-A9BA-CC7043B9F509 Q33570078-3200A3C8-380C-4AB7-BAF0-B2F2DED29BB1 Q33613902-6D2AFC7F-528D-40F3-A36F-D27D6772B7C9 Q33623814-44A5F3EF-19FA-4879-B888-5128ADB37066 Q33675230-D0E6A71D-7DBF-4F7A-82BC-D2A0F69CAAF5 Q33860198-37C89016-DFB8-47D2-9FD7-8CA8477E6AD0 Q34359089-FD7A2089-ED65-48A5-B2D1-7BACE613866B Q34415785-06AD3E75-D9DF-4313-84EE-41E560680776 Q34465326-50DA3B1C-822A-4737-92C6-A4F8BA88DA5B Q34529432-5551C41E-A39D-4236-9A2C-DB6A86237CDF Q34535160-39DB18B6-5B5B-4C0F-B338-9BFF29B61574 Q34600004-C9F89BA8-FC44-4C8B-837D-C3032635116A Q34664064-318DE265-EA0F-45E9-B876-6AF74C20E1C6 Q35025542-5ACA8A70-1236-4190-8E89-19BCA8F79872 Q35074374-2B08810B-245C-439D-B5D4-D6CF36D90A80 Q35647771-6CC6879C-9F3D-48F6-84A4-F6C3AD2CCC2B Q35738930-7F83A570-DBBA-4402-81B1-7571EAB150BC Q35852635-E9E5A151-4C2E-4398-9C49-489F091FE01C Q35861795-932FAA01-F5A6-4DE7-8FB7-F809CF514CAF Q36134308-433AE4E1-C251-47B8-A59A-816D69711BA8 Q36211104-1CFBF468-7B11-4480-8D4C-8AA66C26E336 Q36219597-80602228-2028-43BA-BBCC-57476A0F336D Q36252837-765BED7E-DF2B-494C-82CD-98BAE84F3721 Q36263415-C0640364-3218-4B63-9E20-039695471ACF Q36735425-D6E0314E-CEA5-4A0E-B779-D9DDBAA1CC0F Q36814083-51A10471-43BD-4FF1-8E9C-739D380A5D80 Q36902491-35A13EB4-15B2-471D-BE23-6A56D7D715A7 Q36910650-35116CEE-E449-4034-912C-AAFC994BF224 Q36933039-D1882407-BA83-4E1F-ADFA-5EBD67795016 Q36951570-A656CD4B-8799-465E-ADDF-08E09A8DC866 Q36961034-5BFB29D2-65DD-4165-9DE1-673ADA354B1F Q37230837-D8EA1916-0684-4EE9-8B0A-4BE127DC0209

P2860

Bacteria-induced uroplakin signaling mediates bladder response to infection

http://www.wikidata.org/entity/Q33438417

description

2009 nî lūn-bûn

@nan

2009 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Bacteria-induced uroplakin signaling mediates bladder response to infection

@ast

Bacteria-induced uroplakin signaling mediates bladder response to infection

@en

type

label

Bacteria-induced uroplakin signaling mediates bladder response to infection

@ast

Bacteria-induced uroplakin signaling mediates bladder response to infection

@en

prefLabel

Bacteria-induced uroplakin signaling mediates bladder response to infection

@ast

Bacteria-induced uroplakin signaling mediates bladder response to infection

@en

P1433

Q33438417-82749A30-7753-411D-B423-80AC5BD5D2D5

P1476

Q33438417-AA773FB5-4DEA-4A8B-97BE-117F9430C9FF

P2093

Q33438417-3F82ECA4-3A48-418F-829A-733D023AF481

Q33438417-447E91DD-CB7E-4C95-A5CC-99AF56898E30

Q33438417-57457BE7-D36E-41D2-9F8D-2DCD4743F406

Q33438417-896D0115-5A93-488F-ADF5-8DE6B4F45946

Q33438417-8A71F623-2238-4D10-ADDF-8F19FDD5AD22

Q33438417-9CB7FD8D-7FB5-4DF3-9B28-64E0317F6CB0

Q33438417-BC416192-61F3-4AD3-962E-3529D0DF9B92

Q33438417-D3ACE8F0-5FD3-464F-BF87-D251CCC944D2

P2860

Q33438417-0206E67F-00CF-41F5-B239-678976937972

Q33438417-06AE1FB8-D08E-4535-9E30-0E68D98A2758

Q33438417-08C2C1B8-EE5D-4787-BA9C-EC2F6C14DD1C

Q33438417-13C93DC3-53C5-4669-AF0B-1D1C0D0E692F

Q33438417-167DBD5F-7DF3-4C41-B53B-EC917160C1A8

Q33438417-16BCB484-05B2-4461-80D6-6265B03F134D

Q33438417-18C58B81-F130-4D4F-947E-EBE18880A077

Q33438417-1AB4E46E-117C-4575-AA28-FB1C498A3E15

Q33438417-22260AA0-106C-449A-B99B-41DEA225E303

Q33438417-26B25A36-B078-4661-A41C-3080A83A6ED7

P304

Q33438417-2F8AC1CC-A553-4C9B-B3F7-FBF80B894D84

P31

Q33438417-E3610D44-91C5-42BD-B359-151F940A5F4B

P356

Q33438417-3E1C2CFB-F860-4CAF-9912-71BAA26F7071

P433

Q33438417-118AC067-2169-43AF-90EB-21CD227D4A79

P478

Q33438417-FA48B89D-C120-40A6-91E1-C0A4EFFA071B

P50

Q33438417-F393D2B7-8C0D-4A4D-B6BA-207D8C6E6D55

P577

Q33438417-2E815101-53CE-4B30-89F3-97A3053BD895

P5875

Q33438417-88316D0E-83BE-4049-9432-D0F325646CD3

P698

Q33438417-99C8BFC6-9B42-4D94-BD14-272A98DC141B

P932

Q33438417-D8335C57-8248-4B0D-934A-DFCE298BD7CF

P356

JOURNAL.PPAT.1000415

P1433

P1476

Bacteria-induced uroplakin signaling mediates bladder response to infection

@en

P2093

Anthony J Schaeffer

http://www.w3.org/2001/XMLSchema#string

Benjamin K Billips

http://www.w3.org/2001/XMLSchema#string

David J Klumpp

http://www.w3.org/2001/XMLSchema#string

Ge Zhou

http://www.w3.org/2001/XMLSchema#string

Praveen Thumbikat

http://www.w3.org/2001/XMLSchema#string

Ruth E Berry

http://www.w3.org/2001/XMLSchema#string

Ryan E Yaggie

http://www.w3.org/2001/XMLSchema#string

Tetiana Zaichuk

http://www.w3.org/2001/XMLSchema#string

P2860

Mammalian uroplakins. A group of highly conserved urothelial differentiation-related membrane proteins

Specific heterodimer formation is a prerequisite for uroplakins to exit from the endoplasmic reticulum

Uroplakins Ia and Ib, two major differentiation products of bladder epithelium, belong to a family of four transmembrane domain (4TM) proteins

Uroplakin IIIb, a urothelial differentiation marker, dimerizes with uroplakin Ib as an early step of urothelial plaque assembly

A new generation of Ca2+ indicators with greatly improved fluorescence properties

Bacterial adhesion to target cells enhanced by shear force

Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination

Tetraspanin functions and associated microdomains

Uroplakin Ia is the urothelial receptor for uropathogenic Escherichia coli: evidence from in vitro FimH binding

FACS-optimized mutants of the green fluorescent protein (GFP)

P304

e1000415

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PPAT.1000415

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24398770

http://www.w3.org/2001/XMLSchema#string

P698

19412341

http://www.w3.org/2001/XMLSchema#string

P932

2669708

http://www.w3.org/2001/XMLSchema#string